These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 24435307)
41. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391 [TBL] [Abstract][Full Text] [Related]
42. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling. Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846 [TBL] [Abstract][Full Text] [Related]
43. Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation. Mohorko E; Glockshuber R; Aebi M J Inherit Metab Dis; 2011 Aug; 34(4):869-78. PubMed ID: 21614585 [TBL] [Abstract][Full Text] [Related]
44. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway. Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507 [TBL] [Abstract][Full Text] [Related]
45. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Ruiz-Canada C; Kelleher DJ; Gilmore R Cell; 2009 Jan; 136(2):272-83. PubMed ID: 19167329 [TBL] [Abstract][Full Text] [Related]
46. Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells. Zhang S; Rong P; Chen Q; Wang W Life Sci; 2019 Sep; 232():116626. PubMed ID: 31276688 [TBL] [Abstract][Full Text] [Related]
47. Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner. Zou P; Yang Y; Xu X; Liu B; Mei F; You J; Liu Q; Pei F Oncol Rep; 2018 Jan; 39(1):298-306. PubMed ID: 29138865 [TBL] [Abstract][Full Text] [Related]
48. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades. Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z Life Sci; 2020 May; 248():117449. PubMed ID: 32088212 [TBL] [Abstract][Full Text] [Related]
49. Resveratrol activates autophagic cell death in prostate cancer cells via downregulation of STIM1 and the mTOR pathway. Selvaraj S; Sun Y; Sukumaran P; Singh BB Mol Carcinog; 2016 May; 55(5):818-31. PubMed ID: 25917875 [TBL] [Abstract][Full Text] [Related]
50. Structural basis for coupling protein transport and N-glycosylation at the mammalian endoplasmic reticulum. Braunger K; Pfeffer S; Shrimal S; Gilmore R; Berninghausen O; Mandon EC; Becker T; Förster F; Beckmann R Science; 2018 Apr; 360(6385):215-219. PubMed ID: 29519914 [TBL] [Abstract][Full Text] [Related]
51. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells. Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705 [TBL] [Abstract][Full Text] [Related]
52. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis. Tan M; Xu J; Siddiqui J; Feng F; Sun Y Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654 [TBL] [Abstract][Full Text] [Related]
53. TRIB1 supports prostate tumorigenesis and tumor-propagating cell survival by regulation of endoplasmic reticulum chaperone expression. Mashima T; Soma-Nagae T; Migita T; Kinoshita R; Iwamoto A; Yuasa T; Yonese J; Ishikawa Y; Seimiya H Cancer Res; 2014 Sep; 74(17):4888-97. PubMed ID: 24962028 [TBL] [Abstract][Full Text] [Related]
54. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer. Jin Y; Cui Z; Li X; Jin X; Peng J Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533 [TBL] [Abstract][Full Text] [Related]
55. PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer. Barber AG; Castillo-Martin M; Bonal DM; Jia AJ; Rybicki BA; Christiano AM; Cordon-Cardo C Cancer Med; 2015 Aug; 4(8):1258-71. PubMed ID: 26033689 [TBL] [Abstract][Full Text] [Related]
56. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism. Sekine Y; Demosky SJ; Stonik JA; Furuya Y; Koike H; Suzuki K; Remaley AT Mol Cancer Res; 2010 Sep; 8(9):1284-94. PubMed ID: 20671065 [TBL] [Abstract][Full Text] [Related]
57. Studying endoplasmic reticulum function in vitro using siRNA. Wilson CM; High S Methods Mol Biol; 2010; 619():389-402. PubMed ID: 20419423 [TBL] [Abstract][Full Text] [Related]
58. SIRPB1 promotes prostate cancer cell proliferation via Akt activation. Song Q; Qin S; Pascal LE; Zou C; Wang W; Tong H; Zhang J; Catalona WJ; Dhir R; Morrell M; Balasubramani GK; Lu Y; Wang Z Prostate; 2020 Mar; 80(4):352-364. PubMed ID: 31905248 [TBL] [Abstract][Full Text] [Related]
59. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion. Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102 [TBL] [Abstract][Full Text] [Related]
60. Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation. Zhou Y; Gu P; Li J; Li F; Zhu J; Gao P; Zang Y; Wang Y; Shan Y; Yang D Oncol Rep; 2017 Nov; 38(5):2629-2636. PubMed ID: 29048678 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]